top of page
FNI Research publications (2015-2021)

New Publications:

  1. Authors: Panchanan Maiti1,2,3,4,5*, Jayeeta Manna1, Joshua Thammathong6, Bobbi Evans6, Kshatresh Dutta Dubey7, Souvik Banerjee6, Gary L. Dunbar1,2,3,4*. Tetrahydrocurcumin has similar anti-amyloid properties as curcumin: an in vitro comparative structure-activity studies

  2. Maiti P, Manna J, Dunbar GL. Curcugreen Treatment Prevented Splenomegaly and Other Peripheral Organ Abnormalities in 3xTG and 5xFAD Mouse Models of Alzheimer's Disease (https://www.mdpi.com/2076-3921/10/6/899) 

  3. Maiti P, Bowers Z, Bourcier-Schultz A, Morse J, Dunbar GL. Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s disease, Alzheimer’s research & therapy, 2021 (In press).

  4. Paladugu L, Gharaibeh A, Kolli N, Learman C, Hall TC, Li L, Rossignol J, Maiti P and Gary L Dunbar. Liraglutide has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer’s Disease. Int. J. Mol. Sci. 2021, (In press).

  5. Abeer Gharaibeh, Maiti P, Culver R, Heileman S, Srinageshwar B, Story D, Spelde K, Paladugu L, Munro N, Muhn N, Kolli N, Rossignol J, Dunbar GL. Solid lipid curcumin particles protect medium spiny neuronal morphology, and reduce learning and memory deficits in the YAC128 mouse model of Huntington’s disease. Int. J. Mol. Sci. 2020, 21(24), 9542.

  6. Maiti P, Manna J, Burch Z, Flaherty DB, Larkin JD, Dunbar GL. Ameliorative properties of boronic compounds on in vitro and in vivo models of Alzheimer’s disease, 2020, Int J Mol Sci, 21(18): E6664.

​

All Publications:

1. Maiti P, Manna J, Burch Z, Flaherty DB, Larkin JD, Dunbar GL. Ameliorative properties of boronic compounds on in vitro and in vivo models of Alzheimer’s disease, 2020, Int J Mol Sci, 21(18): E6664. 

​

2. Maiti P, Plemmons AE, Dunbar GL. Combination treatment of Berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments, PLoS One. 2019 Dec 16;14(12): e0225660.

​

3. Maiti P, Bowers Z, Plemmons A, Weaver C, Dunbar GL. Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin. J Vis Exp. 2019 Nov 1;(153). doi: 10.3791/60377.

​

4. Maiti P, Peruzzaro S, Kolli N, Al-Gharaibeh A, Andrews M, Pupiec O, Resk M, Rossignol J, Dunbar GL. Transplantation of mesenchymal stem cells overexpressing interleukin-10 induces autophagy, mitophagy, molecular chaperone responses and promotes neuroprotection in a rat model of traumatic brain injury. J Cell Mol Med. 2019; 00:1–14.

​

5.​Dunbar GL, Koneru S, Kolli N, Sandstrom M, Maiti P, Rossignol J. Silencing of the Mutant Huntingtin Gene through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington's Disease. Cell Transplantation. 2019, 4:963689719840662.

​

6. Maiti P, Scott J, Sengupta D, Al-Gharaibeh A, Dunbar G. Curcumin and Solid Lipid Curcumin Particles Induce Autophagy but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells. International Journal of Molecular Sciences, 2019 Int J Mol Sci. 2019 Jan 18;20(2).

​

7. Peruzzaro ST, Andrews MM, Al-Gharaibeh A, Pupiec O, Resk MR, Story D, Maiti P, Rossignol J, Dunbar G. Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10 promotes. J of Neuroinflammation, 2019, 5;16(1):2.

​

8. Ahn KC, Learman CR, Dunbar GL, Maiti P, Jang WC, Cha HC, Song MS. Characterization of impaired cerebrovascular structure in APP/PS1 mouse brains. Neuroscience, 2018, S0306-4522(18)30326-9.

 

9. Maiti P, Paladugu L, Dunbar GL. Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than dietary curcumin in the 5xFAD mouse model of Alzheimer’s disease. BMC Neurosci. 2018 Feb 23;19(1):7.

 

10. Veleri S, Punnakkal P, Dunbar GL, Maiti P. Molecular insights on the roles of Rab proteins in intracellular dynamics and neurodegenerative diseases, Journal NeuroMolecular Medicine, 2018, 20(1):18-36.

 

11. Maiti P, Al-Gharaibeh A, Kolli N, Dunbar GL. Solid lipid curcumin particles induce more DNA fragmentation and cell death in human glioblastoma than does natural curcumin, Oxidative Medicine and cellular longevity, Volume 2017 (2017), Article ID 9656719, 17 pages.

 

12. Al-Gharaibeh, A Culver R….Maiti P, Dunbar, GL, Rossignol J. Induced neural stem cell transplantation reduced behavioral deficits and ameliorated neuropathological changes in YAC128 Mouse Model of Huntington’s Disease. Frontiers Neurosciences 2017, 11: 628.

 

13. Maiti P, Manna J, Dunbar, GL. Current understanding of the molecular mechanisms underlying the causes of Parkinson's disease and targets for potential treatments, Translational Neurodegeneration, 2017, 6:28.

 

14. Kolli N, Lu M, Maiti P, Rossignol J, Dunbar GL. Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases. Neurochemistry International, 2017, S0197-0186(17)30127-4. 

 

15. Kolli N, Lu M, Maiti P, Rossignol J, Dunbar GL. CRISPR-Cas9-mediated gene silencing of the mutant Huntingtin gene in in vitro model of Huntington’s disease. International Journal of Molecular Science, 2017, 18(4):754

 

16. Maiti P, Dunbar DL. Comparative neuroprotective effects of dietary curcumin and solid lipid curcumin particles in cultured mouse neuroblastoma cells after exposure to Aβ42. International journal of Alzheimer’s Disease 2017, 2017: 1-13

 

17. Maiti P, Rossignol J, Dunbar DL. Curcumin modulates molecular chaperones and autophagy lysosomal pathways in rat cortical neurons after exposure to Aβ42. Journal of Alzheimer’s disease and Parkinsonism 2017, 7(1): 1-12

​

18. Maiti P, Hall TC, Paladugu L, Koli N, Learman C, Rossignol J, Dunbar, GL. A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice. Histochemistry and Cell Biology, 2016, 12; 146(5):609-625.

 

19. Maiti P, Manna J, Ilavazhagan G, Rossignol J, Dunbar GD. Molecular regulation of dendritic spine dynamics and their potential impact on synaptic plasticity and neurological diseases. Neuroscience & Biobehavioral Review, 2015, S0149-7634(15)30106-8.

​

20. Maiti P, Bowers Z, Bourcier-Schultz A, Morse J, Dunbar GL. Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer’s disease, Alzheimer’s research & therapy, 2021 (In press).

​

21. Paladugu L, Gharaibeh A, Kolli N, Learman C, Hall TC, Li L, Rossignol J, Maiti P and Gary L Dunbar. Liraglutide has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer’s Disease. Int. J. Mol. Sci. 2021, (In press).

​

22. Abeer Gharaibeh, Maiti P, Culver R, Heileman S, Srinageshwar B, Story D, Spelde K, Paladugu L, Munro N, Muhn N, Kolli N, Rossignol J, Dunbar GL. Solid lipid curcumin particles protect medium spiny neuronal morphology, and reduce learning and memory deficits in the YAC128 mouse model of Huntington’s disease. Int. J. Mol. Sci. 2020, 21(24), 9542.

​

23. Maiti P, Manna J, Burch Z, Flaherty DB, Larkin JD, Dunbar GL. Ameliorative properties of boronic compounds on in vitro and in vivo models of Alzheimer’s disease, 2020, Int J Mol Sci, 21(18): E6664.

bottom of page